Koncentrationen af urinmarkører for knogleresorption CTx (C- terminaltelopeptid frigjort fra Type I kollagen) blev signifikant reduceret i Bondronat gruppen i forhold til placebo.
Urinary concentrations of the bone resorption marker CTx (C-terminal telopeptide released from Type I collagen) were significantly reduced in the Bondronat group compared to placebo.